Literature DB >> 3916657

DNA repair and resistance to chemotherapy.

A L Harris1.   

Abstract

DNA repair is an important mechanism of chemotherapy resistance in common human tumours. The normal tissues tolerate the drugs also, hence elucidation of normal pathways, rather than markedly resistant mutants, is more likely to be relevant. Specific repair mechanisms may deal with certain lesions (eg O6-methylguanine) but other more general mechanisms (excision repair, poly ADP ribose) can handle a wide range of lesions. The response of human cells to DNA damage is more complex than simply removing lesions. Interactions with growth factors, induction of receptors for growth factors, production of soluble mediators and secretion of plasminogen activator are parts of a cellular and tissue response. These processes may be more active in earlier, less differentiated cells which are more resistant to radiotherapy and chemotherapy. The genetic instability of cancer cells may be related to inappropriately activated DNA repair pathways.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3916657

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  6 in total

Review 1.  Nucleotide excision repair and cancer.

Authors:  Diana Leibeling; Petra Laspe; Steffen Emmert
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 3.156

Review 2.  Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

Authors:  Piet Borst
Journal:  Open Biol       Date:  2012-05       Impact factor: 6.411

3.  Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells.

Authors:  Cheng-Ying Shen; Li-Han Chen; Yu-Fen Lin; Liang-Chuan Lai; Eric Y Chuang; Mong-Hsun Tsai
Journal:  Oncotarget       Date:  2016-11-29

Review 4.  mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.

Authors:  Pankaj Gupta; Zao-zhong Su; Irina V Lebedeva; Devanand Sarkar; Moira Sauane; Luni Emdad; Michael A Bachelor; Steven Grant; David T Curiel; Paul Dent; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2006-02-07       Impact factor: 12.310

Review 5.  The rediscovery of platinum-based cancer therapy.

Authors:  Sven Rottenberg; Carmen Disler; Paola Perego
Journal:  Nat Rev Cancer       Date:  2020-10-30       Impact factor: 60.716

6.  Mathematical modelling of tumour response in primary breast cancer.

Authors:  D A Cameron; W M Gregory; A Bowman; R C Leonard
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.